The invention relates to derivative compounds of partially-reduced isoquinoline with substitution of a sec-butyl group at position 3 with calpain inhibitor activity. The inventive compound comprises an ester or amide derived from (3-sec-butyl-1-oxo-2,3-dihydro-1H-isoquinolin-4-yliden)-acetic acid and (3-sec-butyl-1-thioxo-2, 3-dihydro-1H-isoquinolin-4-yliden)-acetic acid. Compounds having formula I or II can be used in the preventive or therapeutic treatment of a degenerative disease.
申请人:Consejo Superior de Investigaciones Cientificas
(CSIC)
公开号:EP1829864A1
公开(公告)日:2007-09-05
The invention relates to derivative compounds of partially-reduced isoquinoline with substitution of a sec-butyl group at position 3 with calpain inhibitor activity. The inventive compound comprises an ester or amide derived from (3-sec-butyl-1-oxo-2,3-dihydro-1H-isoquinolin-4-yliden)-acetic acid and (3-sec-butyl-1-thioxo-2,3-dihydro-1H-isoquinolin-4-yliden)-acetic acid. Compounds having formula I or II can be used in the preventive or therapeutic treatment of a degenerative disease.
本发明涉及部分还原的异喹啉的衍生物化合物,其第 3 位上的仲丁基被取代,具有钙蛋白酶抑制剂活性。本发明化合物包括由(3-仲丁基-1-氧代-2,3-二氢-1H-异喹啉-4-亚基)-乙酸和(3-仲丁基-1-硫代-2,3-二氢-1H-异喹啉-4-亚基)-乙酸衍生的酯或酰胺。具有式 I 或式 II 的化合物可用于退行性疾病的预防或治疗。